SynEVOL R&D develops AI-guided biomedical platforms — from targeted nanocarrier cancer therapy to post-stroke neural regeneration. These interactive simulations visualize our published research at the molecular and cellular level.
Click any simulation to launch fullscreen. Each visualization is based on SynEVOL's published research and peer-archived data.
Watch 120nm folate-PEGylated liposomes navigate the bloodstream, exploit EPR effect, lock onto FR-α receptors on cancer cells, and release Aquorvitium™ payload via pH-triggered endosomal rupture. Complete tumor eradication. Zero healthy cell damage.
Full cinematic sequence: ischemic stroke damage assessment, 3D bioprinted hydrogel scaffold deployment, neural stem cell seeding, axon growth along scaffold lattice, myelination, synaptogenesis, and complete motor/speech cortex recovery.
Interactive molecular-scale visualization of the Aquorvitium™ delivery vehicle. Cross-section, surface, and exploded views showing all 6 molecular layers — PEG corona, folate ligands, lipid bilayer, pH-sensitive zone, and Aquorvitium™ core. Scale reference vs HIV, DNA, red blood cells.
AI-decoded nerve signal transmission to synthetic limb. Real-time motor command translation, sensory feedback loop, and bidirectional brain-prosthetic communication at the synaptic level.
Nanocarriers delivering growth factors to infarcted cardiac muscle. Cardiomyocyte reactivation, coronary perfusion restoration, and EKG normalization from flatline to sinus rhythm.
Peer-archived research with DOI registration, ORCID attribution, SHA-256 verification, and CC BY-NC-ND 4.0 licensing.
Comprehensive framework integrating molecular dynamics simulation, Monte Carlo tumor modeling, and ML-assisted formulation optimization for folate-targeted pH-responsive liposomal delivery of Aquorvitium™.
120nm folate-PEGylated liposomal systems achieving 60% systemic toxicity reduction, 2.3× improved IC50 vs doxorubicin, 89% FR-α+ cell internalization, and 85% payload release at pH ≤5.5.
Original theoretical framework applying physics principles to cybersecurity architecture modeling. Foundational cross-disciplinary research connecting SynEVOL's computational and biomedical methodologies.
SynEVOL's platform combines machine learning formulation optimization, molecular dynamics simulation, and proprietary Aquorvitium™ chemistry to deliver therapeutics with surgical precision.